- RecruitingPHASE1
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
This study is testing a new combination of two drugs, ASTX660 and pembrolizumab, for people with advanced cancers like cervical cancer and a type of breast cancer. It's a first step to see if this new approach can boost the body's own immune system to fight cancer.
For: Advanced Cancer · Cervical Cancer · Triple Negative Breast CancerUnited Kingdom - Active not recruitingPHASE1, PHASE2
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
This study looks at a new drug, ASTX660, for people with advanced cancers like solid tumours and lymphomas. It checks how safe the drug is, the best dose to use, and if it helps shrink tumours, especially when standard treatments aren't working.
For: Solid Tumors · LymphomaUnited States · Belgium · Canada